Role of neurosteroids in the anticonvulsant activity of midazolam

British Journal of Pharmacology

Volumn 165, Issue 8, 2012, Pages 2684-2691

  Dhir, Ashish ^a   Rogawski, Michael A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clonazepam; Finasteride; Metyrapone; Midazolam; Neurosteroid; Pentylenetetrazol; Peripheral benzodiazepine receptor; PK 11195

Indexed keywords

CARRIER PROTEIN; CLONAZEPAM; FINASTERIDE; METYRAPONE; MIDAZOLAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEUROSTEROID; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; INHIBITION KINETICS; MALE; MOUSE; NEUROSTEROIDOGENESIS; NONHUMAN; PRIORITY JOURNAL; SEIZURE THRESHOLD; STEROIDOGENESIS;

5-ALPHA REDUCTASE INHIBITORS; ANIMALS; ANTICONVULSANTS; CLONAZEPAM; CONVULSANTS; DISEASE MODELS, ANIMAL; FINASTERIDE; GABA ANTAGONISTS; ISOQUINOLINES; MALE; MICE; MIDAZOLAM; NEUROTRANSMITTER AGENTS; PENTYLENETETRAZOLE; RECEPTORS, GABA; SEIZURES;

EID: 84859060166     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01733.x     Document Type: Article

References (54)

1. Akula KK, Dhir A, Kulkarni SK (2009). Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice. Methods Find Exp Clin Pharmacol 31: 423-432.
2. th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
3. Auta J, Romeo E, Kozikowski A, Ma D, Costa E, Guidotti A (1993). Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3- indoleacetamide and imidazopyridine derivatives. J Pharmacol Exp Ther 265: 649-656. (Pubitemid 23315570)
4. Bender AS, Hertz L (1987). Pharmacological characteristics of diazepam receptors in neurons and astrocytes in primary cultures. J Neurosci Res 18: 366-372.
5. Bitran D, Foley M, Audette D, Leslie N, Frye CA (2000). Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl) 151: 64-71. (Pubitemid 30639841)
6. Cavallaro S, Korneyev A, Guidotti A, Costa E (1992). Diazepam-binding inhibitor (DBI)-processing products, acting at the mitochondrial DBI receptor, mediate adrenocorticotropic hormone-induced steroidogenesis in rat adrenal gland. Proc Natl Acad Sci U S A 89: 10598-10602.
7. Dhir A, Zolkowska D, Murphy RB, Rogawski MA (2011). Seizure protection by intrapulmonary delivery of propofol hemisuccinate. J Pharmacol Exp Ther 336: 215-222.
8. A receptors with alternatively spliced variants of the γ2 subunit. Korean J Anesthesiol 60: 109-118.
9. Farrant M, Nusser Z (2005). Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors. Nat Rev Neurosci 6: 215-229. (Pubitemid 40342416)
10. Finn DA, Beadles-Bohling AS, Beckley EH, Ford MM, Gililland KR, Gorin-Meyer RE et al. (2006). A new look at the 5α-reductase inhibitor finasteride. CNS Drug Rev 12: 53-76. (Pubitemid 44133580)
11. Frye CA, Paris JJ, Rhodes ME (2009). Increasing 3α,5α-THP following inhibition of neurosteroid biosynthesis in the ventral tegmental area reinstates anti-anxiety, social, and sexual behavior of naturally receptive rats. Reproduction 137: 119-128.
12. Galvin GM, Jelinek GA (1987). Midazolam: an effective intravenous agent for seizure control. Arch Emerg Med 4: 169-172. (Pubitemid 18067180)
13. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G et al. (1999). Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51: 629-650.
14. Guarneri P, Guarneri R, Cascio C, Piccoli F, Papadopoulos V (1995). γ-Aminobutyric acid type A/benzodiazepine receptors regulate rat retina neurosteroidogenesis. Brain Res 683: 65-72.
15. A receptors. Pharmacol Ther 116: 7-19.
16. Jaimovich DG, Shabino CL, Noorani PA, Bittle BK, Osborne JS (1990). Intravenous midazolam suppression on pentylenetetrazol-induced epileptogenic activity in a porcine model. Crit Care Med 18: 313-316. (Pubitemid 20086863)
17. Kaminski RM, Rogawski MA (2011). 11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis. Neuropharmacology 2011: 133-137.
18. Kita A, Furukawa K (2008). Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice. Pharmacol Biochem Behav 89: 171-178.
19. Kita A, Kohayakawa H, Kinoshita T, Ochi Y, Nakamichi K, Kurumiya S et al. (2004). Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. Br J Pharmacol 142: 1059-1072. (Pubitemid 39093001)
20. Kokate TG, Svensson BE, Rogawski MA (1994). Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 270: 1223-1229. (Pubitemid 24315243)
21. Kokate TG, Banks MK, Magee T, Yamaguchi S, Rogawski MA (1999). Finasteride, a 5α-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther 288: 679-684. (Pubitemid 29119681)
22. Kucken AM, Teissére JA, Seffinga-Clark J, Wagner DA, Czajkowski C (2003). Structural requirements for imidazobenzodiazepine binding to GABA(A) receptors. Mol Pharmacol 63: 289-296. (Pubitemid 36158364)
23. Lacapère JJ, Papadopoulos V (2003). Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 68: 569-585.
24. Lawrence C, Martin BS, Sun C, Williamson J, Kapur J (2010). Endogenous neurosteroid synthesis modulates seizure frequency. Ann Neurol 67: 689-693.
25. Le Fur G, Vaucher N, Perrier ML, Flamier A, Benavides J, Renault C et al. (1983). Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci 33: 449-457. (Pubitemid 13064786)
26. Mak JC, Barnes PJ (1990). Peripheral type benzodiazepine receptors in human and guinea pig lung: characterization and autoradiographic mapping. J Pharmacol Exp Ther 252: 880-885. (Pubitemid 20101913)
27. Marangos PJ, Patel J, Boulenger JP, Clark-Rosenberg R (1982). Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol Pharmacol 22: 26-32. (Pubitemid 12097258)
28. Matsumoto T, Ogata M, Koga K, Shigematsu A (1994). Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice. Antimicrob Agents Chemother 38: 812-816. (Pubitemid 24114023)
29. McCauley LD, Park CH, Lan NC, Tomich JM, Shively JE, Gee KW (1995). Benzodiazepines and peptides stimulate pregnenolone synthesis in brain mitochondria. Eur J Pharmacol 276: 145-153.
30. Mizoule J, Gauthier A, Uzan A, Renault C, Dubroeucq MC, Guérémy C et al. (1985). Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO5-4864, in a conflict situation in the rat. Life Sci 36: 1059-1068. (Pubitemid 15147637)
31. Mukhin AG, Papadopoulos V, Costa E, Krueger KE (1989). Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci U S A 86: 9813-9816. (Pubitemid 20030724)
32. A receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60: 243-260.
33. Orebaugh SL, Bradford SM (1994). Intravenous versus intramuscular midazolam in treatment of chemically induced generalized seizures in swine. Am J Emerg Med 12: 284-287. (Pubitemid 24149396)
34. Papadopoulos V, Guarneri P, Kreuger KE, Guidotti A, Costa E (1992). Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc Natl Acad Sci U S A 89: 5113-5117.
35. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P et al. (2006). Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27: 402-409. (Pubitemid 44069585)
36. Pieri L (1983). Preclinical pharmacology of midazolam. Br J Clin Pharmacol 16 (Suppl. 1): 17S-27S.
37. Raines A, Henderson TR, Swinyard EA, Dretchen KL (1990). Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus. Epilepsia 31: 313-317. (Pubitemid 20181301)
38. Areceptor function and seizure susceptibility. J Neurosci 22: 3795-3805.
39. Reddy DS, Kim HY, Rogawski MA (2001). Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 42: 328-336. (Pubitemid 32275911)
40. Rogawski MA (2002). Principles of antiepileptic drug action. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (eds). Antiepileptic Drugs, 5th edn. Lippincott Williams & Wilkins: Philadelphia, PA, pp. 3-22.
41. Rogawski MA, Reddy DS (2004). Neurosteroids: endogenous modulators of seizure susceptibility. In: Rho JM, Sankar R, Cavazos J (eds). Epilepsy: Scientific Foundations of Clinical Practice. Marcel Dekker: New York, pp. 319-355.
42. Romeo E, Cavallaro S, Korneyev A, Kozikowski AP, Ma D, Polo A et al. (1993). Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex. J Pharmacol Exp Ther 267: 462-471. (Pubitemid 23325041)
43. A-mediated IPSPs of rat hippocampal neurons. J Neurophysiol 70: 1076-1085.
44. Rupprecht R, Ströhle A, Hermann B, di Michele F, Spalletta G, Pasini A et al. (1998). Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers. Biol Psychiatry 44: 912-914. (Pubitemid 28520230)
45. Rupprecht R, Rammes G, Eser D, Baghai TC, Schüle C, Nothdurfter C et al. (2009). Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325: 490-493.
46. 2L γ-aminobutyric acid type A receptors. Anesthesiology 102: 783-792.
47. 3H] Ro5-4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur J Pharmacol 71: 173-175.
48. Serra M, Madau P, Chessa MF, Caddeo M, Sanna E, Trapani G et al. (1999). 2-Phenyl-imidazo[1,2-a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats. Br J Pharmacol 127: 177-187. (Pubitemid 29213247)
49. So EC, Chang YT, Hsing CH, Poon PW, Leu SF, Huang BM (2010). The effect of midazolam on mouse Leydig cell steroidogenesis and apoptosis. Toxicol Lett 192: 169-178.
50. Stell BM, Brickley SG, Tang CY, Farrant M, Mody I (2003). Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-containing GABAA receptors. Proc Natl Acad Sci U S A 100: 14439-14444. (Pubitemid 37499255)
51. Tokuda K, O'Dell KA, Izumi Y, Zorumski CF (2010). Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis. J Neurosci 30: 16788-16795.
52. Tsuda M, Suzuki T, Misawa M (1998). Subsensitivity to mitochondrial diazepam binding inhibitor receptor agonist FGIN-1-27-induced antiseizure effect in diazepam-withdrawn mice. Life Sci 62: PL213-PL217.
53. Ugale RR, Mittal N, Hirani K, Chopde CT (2004). Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice. Brain Res 1023: 102-111. (Pubitemid 39195339)
54. Verleye M, Akwa Y, Liere P, Ladurelle N, Pianos A, Eychenne B et al. (2005). The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. Pharmacol Biochem Behav 82: 712-720. (Pubitemid 43184049)